AR and prostate cancer: Antagonistic pleiotropy arising from selection for prostate-expressed genes and their implication on prostate cancer have been formally proposed (Summers and Crespi 2008), but the promising role of AR CAGn in explaining missing heritability by modulating prostate cancer risk and progression via interactions with circulating androgen levels may deserve increased attention.